The storied success of sildenafil has undeniably transformed the drug landscape. However, wagering in companies heavily dependent on biosimilars and the declining patent exclusivity surrounding this https://bookmarkjourney.com/story21392650/the-blue-pill-and-pharma-a-uncertain-opportunity